08:00 , Feb 5, 2015 |  BC Innovations  |  Distillery Therapeutics

Therapeutics: Kruppel-like factor 10 (KLF10)

Cancer INDICATION: Cancer In vitro studies suggest a new KLF10 inhibitor could help improve the efficacy of cancer immunotherapy. The transcription factor KLF10 regulates conversion of T cells into T regulatory cells (Tregs) that suppress lymphocyte infiltration...